Viral Hepatitis

This is an exciting time for the treatment of viral hepatitis, and being part of that development by attending the EASL Congress 2023 is a fascinating experience! The viral hepatitis track will present phase 3 studies on hepatitis delta, practice-changing news on how we treat patients, and information on new drugs and compounds that are already making their way into clinical practice. The congress will also feature interesting new aspects of hepatitis C from the public health perspective, focusing on how we can achieve the goal of eradicating viral hepatitis from the community. Novel treatment options and durations, and what should be considered together with those living with the disease will be explored. 

Participants will hear from experts who will discuss what will shape the field in future years. The sessions will also provide a great opportunity for delegate networking and discussion; and for industry stakeholders to showcase results.